Morgan Stanley
REVB icon

Morgan Stanley’s Revelation Biosciences REVB Stock Holding History

Morgan Stanley’s Portfolio REVB Stock Details REVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Hold
0
– -$3 – 8195
2024
Q4 		– Hold
0
– – – 7947
2024
Q3 		– Hold
0
– – – 7888
2024
Q2 		– Hold
0
– – – 7780
2024
Q1 		– Hold
0
– – – 7747
2023
Q4 		– Hold
0
– – – 7423
2023
Q3 		– Hold
0
– – – 7457
2023
Q2 		– Hold
0
– – – 7486
2023
Q1 		– Hold
0
– – – 7531
2022
Q4 		– Hold
0
– – – 7496
2022
Q3 		– Hold
0
– – – 7593
2022
Q2 		– Hold
0
– – – 7405
2022
Q1 		– Hold
0
– – – 7587

Other funds holding REVB

TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return